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A B S T R A C T
Background: The formulation of low‑dose oral contraceptive pill (OCP) has not been able to completely eliminate the 
cardiovascular risks associated with its use. Studies have associated serum calcium with metabolic syndrome, high blood 
pressure and lipids in the general population. Aim: To examine the association of serum total calcium with lipids levels and 
blood pressure in young Nigerian women who use OCP. Subjects and Methods: Fasting serum triglyceride, total cholesterol, 
high‑density lipoprotein cholesterol (HDL‑c), low‑density lipoprotein cholesterol (LDL‑c), very low‑density lipoprotein 
cholesterol (VLDL‑c), total lipids and total calcium were assayed in 160 young women (110 OCP users and 50 controls) using 
colorimetric methods. Body mass index (BMI) and blood pressure were also measured. Results: Serum triglyceride (1.19(0.01) 
vs 0.94(0.02), total cholesterol (4.08(0.06) vs 3.52 (0.05), LDL‑c (1.79(0.04) vs 1.24 (0.02), VLDL‑c (0.25(0.02) vs 0.18(0.03), total 
lipids (7.55(0.2) vs 6.26(0.2), total calcium (2.25(0.01) vs 2.06(0.03), systolic (108.9(0.9) vs 103.1(0.9) and diastolic (67.7(0.7) vs 
65.0(0.5) blood pressures were significantly higher (P < 0.001) in OCP users than non‑users. Conversely, HDL‑c levels in OCP 
users were lower (1.77(0.08) vs 1.84(0.02); P = 0.30) compared with non-users. Serum calcium positively correlated with blood 
pressure and lipid parameters except HDL‑c in women OCP users. Women on OCP who had lower serum total calcium levels had 
statistically significant lower lipid parameters while those women on OCP who had higher serum calcium levels had significantly 
higher lipid parameters. The BMI of both study population and control was not significantly different. Conclusion: Low-dose 
OCPs induce increased levels of serum lipids, calcium and blood pressures. Serum total calcium level was positively associated 
with blood pressure, measured lipid parameters except HDL‑c in women on OCP. These data suggest that serum calcium may 
have some influences on lipids and blood pressure in subjects who use OCP irrespective of their BMI.
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INTRODUCTION
The use of oral contraceptive pills (OCP) by Nigerian 
women has increased over the years. The report of the 
family planning Survey carried out by the Federal Office of 
Statistics indicated a substantial increase in the rate of OCP 
use among Nigerian women of reproductive age.[1] Prior to 
the introduction of low-dose OCP, the first generation of 
OCP	which	contained	high	dose	ethinyl	estradiol	(≥50	µg) 
and progestin were associated with several adverse effects 
including cardiovascular risk factors.[2] In order to minimize 
the adverse effects, low-dose OCP was formulated.[2-4] The 
introduction of this low-dose OCP did not completely 
eliminate the association of OCP use with cardiovascular 
and other risks.[5] We previously reported on the effect of 
OCP on some lipids and electrolytes levels in women of 
different hemoglobin genotypes[6] and effect of duration 
of OCP use on lipid levels.[7] Tanis et al.[8] reported that 
hypercholesterolemia was the most important risk factor 
for myocardial infarction in women who are users of 
OCP. It was observed that association of OCP with other 
risk factors may lead to changes in the cardiovascular risk 
profile. Studies that investigated arterial events in OCP users 
have shown some associations with clinical identifiable risk 
factors such as obesity and hypertension.[9,10]
Serum calcium plays an important pathophysiologic role 
in cardiovascular[11] and kidney functions.[12] Studies have 
reported an association between serum calcium and 
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metabolic syndrome,[13] high blood pressure,[14] and lipids[15] in 
the general population. Calcium deficiency may lead various 
diseases such as osteoporosis, arthritis, hypertension[16] 
while its excess also has negative consequences on the 
reproductive health in experimental animals.[17] Excess 
calcium salt in the body has been reported as castrative 
agent[18] but others contradict its chemocastrative role.[19] 
Calcium has been reported to have oxidative and nitrosative 
stress effects in the body.[20] High calcium levels in the 
body main lead to decrease body weight of testes and 
other accessory sex organs in a dose- and time-dependent 
manner. The mechanism by which excess calcium 
correlates negatively with body weight could be either by 
increasing core body temperature[21] or reduced body fat 
accumulation.[22] Excess calcium has also been reported to 
affect the concentration of sex hormones in rats.[9] Report 
on the association of serum calcium with lipids and blood 
pressure in women who are users of low-dose OCP is scarce. 
High serum calcium levels were observed to be positively 
associated with high blood pressure in a representative 
sample of United States of American adults without 
cardiovascular diseases (CVDs) which was independent of 
age, sex, race, alcohol, smoking, diabetes, lipids, serum 
albumin, serum vitamin D and phosphorus.[23] Calcium 
is an important intracellular messenger that is involved 
throughout the life cycle of an organism to control very 
many biological processes.[24] Subjects with calcium intake 
above the estimated average requirement (EAR) exhibited 
significantly greater serum high-density lipoprotein 
cholesterol (HDL-c) levels than those with a calcium intake 
below EAR.[25] It was suggested that diabetes mellitus and 
CVDs are linked by a common defect of divalent cation 
metabolism including calcium.[26] Epidemiological evidence 
shows link between abnormality of lipid profile and 
variations in calcium levels. There is need to know whether 
an increase in the levels of serum calcium are associated 
with changes in lipid concentrations in women who are 
users of OCP. This study therefore examines any possible 
association between serum total calcium and lipid levels 
as well as blood pressure in ambulatory young Nigerian 
women who were current users of OCP.
SUBJECTS AND METHODS
Subjects’ preparation
After ethical approval by relevant authorities, all subjects 
who gave informed consent and met the inclusion criteria 
were consecutively recruited in the study. They consisted of 
110 young women on OCP and 50 young women non-OCP 
users who were on typical Nigerian diet of high carbohydrate 
and low fat. The study group was receiving combined biphasic 
lo femenal tablets (Wyeth Laboratory Inc. Philadelphia, 
USA) which contains 0.03 mg ethinyl estradiol and 0.3 mg 
norgestrel for a minimum of 6 months. They were subjects 
with regular menstruation, no history of metabolic disease 
and were not on calcium supplementation. The control group 
was young women with consistent menstrual cycle for the 
last six consecutive months, no history of metabolic disease, 
not on calcium supplementation and no history of hormonal 
therapy within the last 6 months before investigation. 
Demographic data were obtained with the help of structures 
questionnaires. The height, weight and blood pressure of 
both study subjects and controls were measured. Height was 
measured to the nearest 0.1 cm and weight was measured to 
the nearest 0.1 kg in light clothing. Body mass index (BMI) was 
calculated as weight (kg) divided by the height squared (m2). 
Blood pressure was measured twice and the latter was used 
in the analysis, in a sitting position after a minimum of 
10 minutes of rest using a mercury sphygmomanometer.
Laboratory methods
After an overnight fast, venous blood sample was collected 
into plain tube in order to obtain serum for lipids and total 
calcium determinations. The blood was allowed to clot at 
room temperature and serum collected after centrifugation 
at 3000 rpm for 10 minutes. The serum was stored at -20oC and 
analyzed within 5 days. Serum triglyceride, total cholesterol 
and HDL-c were assayed by enzyme catalyzed colorimetric 
technique using kits supplied by Randox Laboratories, 
UK. While low-density lipoprotein cholesterol (LDL-c) was 
calculated using the Friedewald equation. Total lipid was 
determined using the method of Zollner and Kirsch.[27] 
Total lipids react with sulfuric acid, phosphoric acid and 
vanillin to form a pink colored complex. A 50 µl of serum or 
standard lipid was added to 2 ml concentrated sulfuric acid. 
The tube was mixed, plugged with cotton wool and stand in 
a boiling water bath for 10 minutes. After 10 minutes, the 
test-tube was removed and then cooled in a cold water bath. 
A 10 µl of the mixture from the above solution was added 
to 2.5 ml of color reagent. This was mixed and allowed to 
stand at room temperature for 30 minutes. The absorbance 
was then read at 540 nm against a reagent blank. Serum 
total calcium was assayed by end point colorimetric method 
using o-cresolphthalein complex one reagent. Quality 
control sera were included in the assays to ensure accuracy 
of measurements.
Statistical analysis
Data are presented as mean (SEM). The Students t-test was 
used to compare the mean values of measured variables 
between the study group and controls. Pearson correlation 
coefficient was calculated to evaluate the relationship 
between serum calcium and other measured variables. 
Statistical analysis was performed using the statistical 
package for social sciences (SPSS-16, Chicago, USA) and a 
P value less than 0.05 was considered significant.
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RESULTS
A total of 160 ambulatory young Nigerian women (110 °OCP 
users, 50 controls, mean (SEM) age 24.1(4) vs 25.2(3), BMI 
28.7(1.2) vs 27.8(1.5) were included in the study. Table 1 
shows the general characteristics and measured biochemical 
variables in women who are current OCP users compared 
with non-OCP users (Controls). The mean age of the 110°CP 
users was not significantly lower (P	=	0.80)	 compared	 to	
the control subjects. The BMI of both study population and 
controls was not significantly different (P	 =	 0.50).	 Both	
systolic and diastolic blood pressures of OCP users was 
significantly higher (P < 0.001) compared to non-OCP 
users. Similarly, serum triglyceride, total cholesterol, LDL-c, 
VLDL-c and total lipids were significantly higher in OCP 
users than non-OCP users. Serum total calcium levels was 
significantly higher (P < 0.001) in the study group compared 
with the control group. Conversely, HDL-c levels in OCP 
users were lower compared to non-OCP users. The different 
was however not statistically significant (P	 =	 0.30).	
Serum total calcium correlated positively (P	=	0.05)	with	
blood pressures, triglyceride, total cholesterol, total lipids 
and LDL-c (P	 =	 0.04),	 but	 HDL-c	 did	 not	 correlate	 with	
serum total calcium in women OCP users. Only total lipids 
significantly correlated (P	=	 0.05)	 with	 serum	 calcium	 in	
non-OCP user [Table 2]. In order to better appreciate the 
relationship between serum total calcium and measured 
lipid parameters, the serum levels of triglyceride, total 
cholesterol, HDL-c, LDL-c, VLDL-c and total lipids were 
stratified based on serum total calcium levels. Women 
OCP users who had serum total calcium concentrations 
of 2.0-2.05 mmol/L had significantly lower (P < 0.001) 
levels of triglyceride, total cholesterol, LDL-c, VLDL-c and 
total lipids compared to those women OCP users who had 
serum total calcium levels of 2.06-2.30 mmol/L. Those with 
lower serum total calcium levels had slightly higher but not 
statistically significant HDL-c level compared with women 
on OCP who had higher serum total calcium levels. When the 
mean values of lipid parameters in subjects who had serum 
calcium concentrations of 2.0-2.05 mmol/L were compared 
with those who had higher calcium levels (2.06-2.30 mmol/L), 
statistically significant differences were observed at various 
levels of significance. Among the control subjects, those 
who had serum calcium levels of 2.06-2.30 mmol/L have 
elevated levels of measured parameters when compared 
with those who lower calcium levels (2.0-2.05 mmol/L), 
but only triglyceride and VLDL-c were statistically 
significant (P	 =	 0.02)	 [Table	 3].	 Higher	 atherogenic	 lipid	
indices were observed in OCP users with higher serum 
calcium levels than those with lower serum calcium levels. 
Serum calcium failed to show a significant correlation with 




These data indicate an association between serum calcium 
and measured lipid levels in women on OCP. A positive 
correlation was observed between triglyceride, total 
cholesterol, LDL-c, VLDL-c, total lipids and total calcium 
levels in women who use OCP. The present study is 
consistent with others.[28,29] Abdel-Barry et al.[28] observed 
that serum triglyceride, total cholesterol, HDL-c and VLDL-c 
levels were significantly higher in OCP users compared 
Table 1: General characteristics and measured biochemical 
variables in women on low‑dose OCP compared with control 
subjects (mean±SEM)
Measured variables Women on OCP Controls P value
Age (years) 24.1 (4.0) 25.2 (3.0) 0.80
Body mass index 28.7 (1.2) 27.8 (1.5) 0.50
Systolic blood pressure (mmHg) 108.9 (0.9) 103.1 (0.9) <0.001
Diastolic blood pressure (mmHg) 67.7 (0.7) 65.0 (0.5) <0.001
Triglyceride (mmol/l) 1.19 (0.01) 0.94 (0.02) <0.001
Total cholesterol (mmol/l) 4.08 (0.06) 3.52 (0.05) <0.001
HDL‑c (mmol/l) 1.77 (0.08) 1.84 (0.02) 0.30
LDL‑c (mmol/l) 1.79 (0.04) 1.24 (0.02) <0.001
VLDL‑c (mmol/l) 0.25 (0.02) 0.18 (0.03) <0.01
Total lipids (g/l) 7.55 (0.20) 6.26 (0.20) <0.001
Total calcium (mmol/l) 2.25 (0.01) 2.06 (0.03) <0.001
OCP – Oral contraceptive pill; HDL – High‑density lipoprotein cholesterol; LDL – Low‑density 
lipoprotein cholesterol; VLDL – Very low‑density lipoprotein cholesterol; SEM – Standard error 
of mean
Table 2: Relationship between serum calcium and other 
measured variables in women on OCP and controls




r value P value r value P value
Calcium and systolic blood pressure 0.199 0.05 0.168 0.46
Calcium and diastolic blood pressure 0.198 0.05 0.166 0.48
Calcium and triglyceride 0.217 0.043 0.170 0.45
Calcium and total cholesterol 0.223 0.042 0.168 0.46
Calcium and LDL cholesterol 0.234 0.02 0.166 0.48
Calcium and HDL cholesterol 0.196 0.06 0.169 0.46
Calcium and total lipids 0.218 0.043 0.276 0.05
OCP – Oral contraceptive pill; HDL – High‑density lipoprotein cholesterol; LDL – Low‑density 
lipoprotein cholesterol
Table 3: Serum lipids levels in relation to calcium concentration 
in women on OCP and controls
Measured 
parameters
 Mean calcium levels in 
OCP users

















0.98 (0.08) 1.50 (0.04) <0.001 0.94 (0.02) 1.00 (0.02) 0.02
Total cholesterol 
(mmol/l)
3.71 (0.04) 4.60 (0.02) <0.001 3.45 (0.02) 3.83 (0.20) 0.08
LDL-cholesterol 
(mmol/l)
1.74 (0.05) 1.86 (0.04) 0.004 1.17 (0.02) 1.38 (0.14) 0.06
HDL‑cholesterol 
(mmol/l)
1.78 (0.02) 1.74 (0.60) 0.5 1.81 (0.01) 2.07 (0.12) 0.07
VLDL-cholesterol 
(mmol/l)
0.20 (0.01) 0.32 (0.05) 0.04 0.44 (0.01) 0.47 (0.01) 0.02
Total lipids (g/l) 6.82 (0.20) 8.64 (0.20) <0.001 6.30 (0.95) 6.67 (1.91) 0.08
OCP – Oral contraceptive pill; HDL – High‑density lipoprotein cholesterol; LDL – Low‑density 
lipoprotein cholesterol
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to non-OCP users, but LDL-c level was significantly lower. 
This observation of lower LDL-c in OCP users disagreed 
with ours where LDL-c was equally higher in OCP users. 
Some authors[1] reported that African American women 
who use low-dose OCP had worse glucose tolerance and 
triglyceride levels. It was also stated that the differences 
between OCP users and non-OCP users in cardiovascular 
risk factors were greater in the subgroup of non-obese 
women on OCP. This observation may indicate additional 
health risks for non-obese women on OCP. This is 
important because our study participants were non-obese 
judging from their BMI values. The observed increased in 
triglyceride, total cholesterol, LDL-c and VLDL-c in OCP 
users may be attributed to enhanced hepatic synthesis and 
secretion of triglyceride-rich particles,[30] total cholesterol 
and modulation of LDL receptor activity.[28-31] Several 
authors have shown that increased triglyceride levels are 
independent risk for CVD[32] and total cholesterol a strong 
predictor of coronary risk especially at young age.[33] The 
observed decrease in HDL-c may be due to up-regulation 
of hepatic lipase activity by androgenic effect of progestin 
leading to increased clearance of HDL-c, thereby lowering 
the circulating HDL-c levels.[30] Even though estrogen has the 
ability to inhibit hepatic lipase activity, it is our belief that 
the overall net effect favors progestin in the regulation of 
HDL-c in users of OCP. This observation is slightly different 
from that reported by Kim et al.[25] They observed that in 
patients with diabetes mellitus, calcium was protective 
against decreasing HDL-c levels without elevating total 
cholesterol levels. The proposed mechanisms by which total 
calcium affects lipid metabolism are that calcium interferes 
with lipid absorption in the gut since it can bound to fatty 
acids and bile salts hydrolase.[15] While HDL-c increasing 
effect of calcium may be through a reduction in the activity 
of plasma cholesteryl ester transport protein (CETP).[25]
We observed a significant association between measured 
lipoproteins except HDL-c and serum total calcium in 
OCP users. A subgroup of women OCP users with calcium 
levels of 2.0-2.05 mmol/L had the lowest concentrations 
of total lipids and lipoproteins, while those with higher 
total calcium levels (2.06-2.3 mmol/L) had the highest 
concentrations of the measured lipids. Similar associations 
between lipids and total calcium were reported in a number 
of studies[34,35] even in the general population without 
any observed confounders. Calcium has been reported to 
modulate lipid metabolism in both experimental animals 
and human studies.[25] Cobb et al.[36] observed that OCP use 
may be detrimental to bone health in exercising women 
with normal menstrual cycles. Studies have also shown 
that physically active women on low-dose OCP had reduced 
bone mineral density (BMD) compared with physically 
active women who do not use OCP.[37,38] Studies associating 
OCP use and calcium are inconsistent, while some linked 
OCP use to decrease in stress fracture risk[39] others 
observed no association.[40] Subjects treated with gonadal 
steroid combination were reported to achieve a positive 
calcium balance with occasional concomitant fall in serum 
calcium levels.[40] The observed association of OCP use 
with serum calcium in this study is agreement with other 
studies.[41-43] It was suggested that OCP may play some roles 
in calcium homeostasis bringing about an overall increase 
in calcium mobilization from the bone resulting in bone 
demineralization, which may predisposes subjects on OCP 
to osteoporosis.[41] The mechanism by which OCP usage 
affects calcium levels is by increasing intestinal absorption 
of dietary calcium and tubular re-absorption through the 
actions of parathyroid hormone (PTH). The Estrogen content 
of OCP appears to inhibit bone mineralization perhaps by 
reducing the response of bone to circulating PTH or by 
directly altering PTH levels. Parathyroid hormone increases 
the activity of 1a-hydroxylase enzyme, which converts 25 
hydroxy cholecalciferol to 1,25 dihydroxycholecalciferol. 
This active form of vitamin D regulates serum calcium levels 
by increasing calcium absorption from diet in the intestine 
and tubular re-absorption of calcium in the kidney.[15,25]
A large Swedish health screening survey reported that 
changes in calcium metabolism, even within the physiological 
range, were related to increased blood pressure, impaired 
glucose tolerance and dyslipidaemia.[44] The increased 
serum total calcium levels in some subjects on low-dose 
OCP may be due to increased intestinal absorption, renal 
absorption, increased skeletal resorption or a combination 
of these factors since these activities are mediated by 
parathyroid hormone (PTH).[10] However, several studies 
on cardio-metabolic outcomes failed to observe clinically 
significant effects of vitamin D supplementation.[18] The 
positive association between total calcium and blood 
pressure as observed in this study is consistent with 
others.[19,45] Yao et al.[45] reported that serum calcium may 
have an influence on blood pressure of older male subjects 
with hypertension and in blood lipid profile of normotensive 
subjects. Willett et al.[46] previously reported an increased 
risk of hypertension among current users of low-dose OCP, a 
frequency that was highest among long-term users. Women 
with a history of high blood pressure may respond readily 
to the hormonal stimulus of OCP with greater increase in 
blood pressure.[46] It was concluded that subjects who use 
OCP may be monitored more closely and thus are more 
likely to be diagnosed with increased blood pressure than 
non-OCP users. Even though the mechanisms involved in 
the production and maintenance of OCP-induced high blood 
pressure are not fully understood, the rennin angiotensin 
system has been implicated.[46] The good news is that 
changes in blood pressure induced by OCP are reversible in 
a short time. Some authors reported that increased blood 
pressure returned to pre-treatment levels within 3 months in 
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a group of women who discontinued OCP after 1-3 years of 
use.[46] On the other hand, a cross-sectional study of women 
on OCP did not observed any significant differences in 
mean systolic and diastolic blood pressure.[47] Bloch[48] even 
observed a slight fall (<2 mmHg systolic and <4 mmHg 
diastolic) in blood pressure among women on OCP which 
contain different doses of progestin.
The limitations of this study are the sample size and the 
inability to measure ionized calcium. Serum total calcium is 
a combination of three forms in the circulation: Ionized or 
free (50%), protein-bound (40%) and soluble form complexed 
with anions such as bicarbonate and phosphate (10%). 
The ionized calcium is the physiologically active form in 
the circulation which is an accurate indicator of calcium 
homeostasis.[49] But its measurement is not readily done in 
our setting; hence, total calcium is routinely used in clinical 
practice to assess calcium status. In studies that evaluated 
ionized calcium levels, no association was reported between 
ionized calcium and blood pressure in several studies.[50,51]
CONCLUSION
Serum calcium, measured lipid parameters, except HDL-c 
and blood pressure were elevated in subjects using 
low-dose OCP. Among OCP users, the sub-group of women 
with higher serum calcium levels had increased atherogenic 
lipid indices compared to those with low serum calcium 
levels. Serum total calcium level correlated positively with 
blood pressure, measured lipid parameters except HDL-c 
in women on OCP. These data suggest that serum calcium 
may exert some influences on lipids and blood pressures in 
women who use OCP irrespective of their BMI.
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